The Native Antigen Company develops and manufactures premium quality antigens and antibodies, as well as offering a range of services to the diagnostic and biopharmaceutical industries. Founded in 2010, it is one of the world’s leading suppliers of infectious disease reagents. With a rapidly expanding product portfolio, the company is widely acknowledged to be a primary source of reagents and kits for the study of emerging diseases. The Native Antigen Company joined LGC in 2020.
The proprietary VirtuE™ expression system has been developed for the purpose of producing native-like proteins, which are widely adopted by leading in vitro diagnostic, vaccine and academic groups in cutting-edge R&D, where correct folding and glycosylation are vital. VirtuE™ has been used to develop >50% of The Native Antigen Company’s products, including recombinant and native antigens, virus-like particles, human cell-surface receptors and bacterial toxins.
Contact LGC Clinical Diagnostics
Whether releasing patient results with confidence or advancing cutting-edge research, you need a partner that is responsive, reliable and agile. Please get in touch and see how we can collaborate to change the future of clinical diagnostics.Get in Touch